Bide Pharmatech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 2, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	5,335	4,342	5,044	5,333	-	-
Market Cap Growth	32.26%	-13.91%	-5.42%	-	-	-
Enterprise Value	4,422	3,260	3,905	3,860	-	-
Last Close Price	61.93	48.17	52.79	55.15	-	-
PE Ratio	35.39	36.98	46.03	36.53	-	-
Forward PE	35.09	31.74	22.50	30.12	-	-
PS Ratio	4.20	3.94	4.62	6.40	-	-
PB Ratio	2.66	2.14	2.41	2.57	-	-
P/TBV Ratio	2.67	2.15	2.42	2.57	-	-
P/FCF Ratio	135.24	62.06	-	-	-	-
P/OCF Ratio	80.24	27.43	-	178.53	-	-
EV/Sales Ratio	3.48	2.96	3.58	4.63	-	-
EV/EBITDA Ratio	21.03	26.38	35.88	25.71	-	-
EV/EBIT Ratio	24.45	28.92	39.33	26.74	-	-
EV/FCF Ratio	112.10	46.59	-	-	-	-
Debt / Equity Ratio	0.12	0.04	0.03	0.02	0.04	0.05
Debt / EBITDA Ratio	1.12	0.58	0.45	0.25	0.23	0.22
Debt / FCF Ratio	5.99	1.18	-	-	-	-
Asset Turnover	0.52	0.46	0.46	0.51	0.86	1.01
Inventory Turnover	0.91	0.93	1.10	0.94	0.91	1.07
Quick Ratio	2.74	4.12	5.54	6.84	1.31	1.59
Current Ratio	4.56	6.39	8.22	9.01	3.28	3.19
Return on Equity (ROE)	7.66%	5.71%	5.21%	10.79%	19.65%	23.58%
Return on Assets (ROA)	4.60%	2.92%	2.60%	5.53%	9.51%	12.30%
Return on Invested Capital (ROIC)	12.88%	9.93%	11.55%	22.92%	25.82%	35.11%
Return on Capital Employed (ROCE)	8.90%	5.40%	4.60%	6.80%	16.40%	20.90%
Earnings Yield	2.87%	2.70%	2.17%	2.74%	-	-
FCF Yield	0.74%	1.61%	-2.35%	-0.16%	-	-
Dividend Yield	1.54%	1.87%	1.70%	1.99%	-	-
Payout Ratio	51.65%	68.03%	91.29%	0.06%	0.19%	42.22%
Buyback Yield / Dilution	2.03%	1.76%	-22.83%	-10.09%	-8.03%	-610.24%
Total Shareholder Return	3.54%	3.63%	-21.13%	-8.10%	-8.03%	-610.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.